Výsledky vyhledávání - "Sydney P. Sharp"

Akademický článek

A technology-enabled multi-disciplinary team-based care model for the management of Long COVID and other fatiguing illnesses within a federally qualified health center: protocol for a two-arm, single-blind, pragmatic, quality improvement professional cluster randomized controlled trial

Autor: Job G. Godino, Jane C. Samaniego, Sydney P. Sharp, Douglas Taren, Alexandra Zuber, Amy J. Armistad, Amanda M. Dezan, Azure J. Leyba, Janna L. Friedly, Aaron E. Bunnell, Eva Matthews, Maureen J. Miller, Elizabeth R. Unger, Jeanne Bertolli, Alison Hinckley, Jin-Mann S. Lin, John D. Scott, Bruce B. Struminger, Christian Ramers

Publikováno v: Trials, Vol 24, Iss 1, Pp 1-15 (2023)

Abstract Background The clinical burden of Long COVID, myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), and other post-infectious fatiguing illnesses (PIFI) is increasing. There is a critical need to advance understanding of the effective

Externí odkaz: https://doaj.org/article/25694e8cfec642e4b38fff1e31c52b81

Zobrazit plný text záznamu

Plný text ve formátu HTML

Akademický článek

COVID-19 monoclonal antibody treatment impact on symptoms and post-COVID conditions among high-risk patients at a Federally Qualified Health Center

Autor: Natalie L. Vawter, Job G. Godino, Sydney V. Lewis, Adam W. Northrup, Jane C. Samaniego, Jacqueline Y. Poblete, Jesus A. Guereca, Sydney P. Sharp, Eva Matthews, Noe C. Crespo, Pauline G. Lucatero, Monica M. Vidaurrazaga, Christian B. Ramers

Publikováno v: BMC Infectious Diseases, Vol 23, Iss 1, Pp 1-14 (2023)

Abstract Background Monoclonal antibody (mAb) treatment for COVID-19 is associated with improved clinical outcomes. However, there is limited information regarding the impact of treatment on symptoms and the prevalence of post-COVID Conditions (PCC).

Externí odkaz: https://doaj.org/article/fc63052ddca240b0a0e8230de667340a

Zobrazit plný text záznamu

Plný text ve formátu HTML

COVID-19 monoclonal antibody treatment impact on symptoms and post-COVID conditions among high-risk patients at a Federally Qualified Health Center

Autor: Natalie L. Vawter, Job G. Godino, Sydney V. Lewis, Adam W. Northrup, Jane Samaniego, Jacqueline Y. Poblete, Alexander Guereca, Sydney P. Sharp, Eva Matthews, Noe C. Crespo, Christian B. Ramers

Background: Monoclonal antibody (mAb) treatment for COVID-19 is associated with improved clinical outcomes. However, there is limited information regarding the impact of treatment on symptoms and the prevalence of post-COVID Conditions (PCC). Underst

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::bf3510672f674b64fec666915e57285e
https://doi.org/10.21203/rs.3.rs-2086199/v1

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání